Next Article in Journal
Correction: Sgherza et al. Efficacy and Safety of Isatuximab, Carfilzomib, and Dexamethasone (IsaKd) in Multiple Myeloma Patients at the First Relapse After Autologous Stem Cell Transplantation and Lenalidomide Maintenance: Results from the Multicenter, Real-Life AENEID Study. Pharmaceuticals 2025, 18, 595
Previous Article in Journal
Real-World Analysis of Short-Term Effectiveness of Oral Semaglutide: Impact on Glycometabolic Control and Cardiovascular Risk
Previous Article in Special Issue
Doxorubicin-Induced Cardiotoxicity and the Emerging Role of SGLT2 Inhibitors: From Glycemic Control to Cardio-Oncology
 
 
Review

Article Versions Notes

Pharmaceuticals 2025, 18(6), 857; https://doi.org/10.3390/ph18060857
Action Date Notes Link
article xml file uploaded 9 June 2025 10:22 CEST Original file -
article xml uploaded. 9 June 2025 10:22 CEST Update https://www.mdpi.com/1424-8247/18/6/857/xml
article pdf uploaded. 9 June 2025 10:22 CEST Version of Record https://www.mdpi.com/1424-8247/18/6/857/pdf
article html file updated 9 June 2025 10:24 CEST Original file -
article html file updated 9 June 2025 11:22 CEST Update https://www.mdpi.com/1424-8247/18/6/857/html
Back to TopTop